Brief: Voyager Therapeutics Q3 EPS USD -0.59
06/11/2023 21:57
Nov 6 (Reuters) - Voyager Therapeutics Q3 EPS USD -0.59. * Q3 basic EPS USD -0.59 * Q3 pretax profit USD -26.078 million * Q3 net income USD -25.901 million * Q3 operating income USD -29.507 million * Q3 collaboration revenue USD 4.614 million
Recent news on Voyager Therapeutics
See all newsBrief: Voyager Names Robin Swartz As President; Expected To Succeed As CEO In Q1 2027
Voyager Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Voyager Therapeutics Q2 collaboration revenue falls, net loss narrows
Brief: Voyager Therapeutics Q2 Net Income USD -24.473 Million
Voyager Therapeutics Inc expected to post a loss of 48 cents a share - Earnings Preview